European Journal of Gynaecological Oncology
Print ISSN: 0392-2936 | Online ISSN: 2709-0086
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal. EJGO publishes on a broad range of gynaecologic oncology topics. Different types of articles are considered for publication (see Aims & Scope) with emphasis on original research to include prospective clinical trials, basic and applied science, case-control, and cohort studies. We also encourage the submission of systematic reviews and meta-analyses.
Articles
Risk factors contributing to the persistent infection of high-risk Human papillomavirus (HPV)
Risk factors contributing to the persistent infection of high-risk Human papillomavirus (HPV)
DOI: 10.22514/ejgo.2025.060
Functional, microarray and bioinformatics analyses of human papillomavirus E7-specific pathways in cervical carcinogenesis
Functional, microarray and bioinformatics analyses of human papillomavirus E7-specific pathways in cervical carcinogenesis
DOI: 10.22514/ejgo.2025.061
Impact of paclitaxel on pazopanib pharmacokinetics in patients with ovarian cancers from phase II trial TAPAZ
Impact of paclitaxel on pazopanib pharmacokinetics in patients with ovarian cancers from phase II trial TAPAZ
DOI: 10.22514/ejgo.2025.062
Surgical outcomes for robotic-assisted single-site hysterectomy compared to multi-port hysterectomy
Surgical outcomes for robotic-assisted single-site hysterectomy compared to multi-port hysterectomy
DOI: 10.22514/ejgo.2025.064
Evaluation of tissue expressions of kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in ovarian neoplasms
Evaluation of tissue expressions of kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in ovarian neoplasms
DOI: 10.22514/ejgo.2025.065
Curcumin enhances breast cancer cell death by suppressing PD-L1 expression
Curcumin enhances breast cancer cell death by suppressing PD-L1 expression
DOI: 10.22514/ejgo.2025.066
Importance of hereditary variants in ovarian cancer and endometrial cancer
Importance of hereditary variants in ovarian cancer and endometrial cancer
DOI: 10.22514/ejgo.2025.067
Breast cancer recurrence time prediction based on the MOPSO-RF model
Breast cancer recurrence time prediction based on the MOPSO-RF model
DOI: 10.22514/ejgo.2025.068
Can elastographic evaluation be a new approach in prediction of endometrial cancer prognostic markers?
Can elastographic evaluation be a new approach in prediction of endometrial cancer prognostic markers?
DOI: 10.22514/ejgo.2025.069
The effect of secondary cytoreductive surgery on survival in recurrent epithelial ovarian cancer
The effect of secondary cytoreductive surgery on survival in recurrent epithelial ovarian cancer
DOI: 10.22514/ejgo.2025.072
Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors
Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors
DOI: 10.22514/ejgo.2025.073
Large pelvic mass invading into the sacrum: a case report for primary retroperitoneal P16 positive squamous cell carcinoma
Large pelvic mass invading into the sacrum: a case report for primary retroperitoneal P16 positive squamous cell carcinoma
DOI: 10.22514/ejgo.2025.074
Published Ahead of Print
Expression and clinical significance of CSAD in type I endometrial carcinoma
Expression and clinical significance of CSAD in type I endometrial carcinoma
Online publish date: 28 October 2024
DOI: 10.22514/ejgo.2024.110
Special Issues
Quality of Life in Gynecologic Malignancies
Keywords: Quality of life; Palliative care; Symptom management
Editor: Lori Spoozak, MD
Submission deadline: 31 December 2024
Endometrial Cancer and Fertility Preservation in the Denatality ERA
Keywords: Endometrial cancer; Fertility preservation; Surgery fertility sparing; Ovarian reserve
Editor: Dr. Giuseppe Gullo, MD, PhD,Dr. Alessandra Lopez, MD,Dr. Valentina Billone, MD, PhD St.
Submission deadline: 31 December 2025
Advances in Ovarian Cancer Research
Keywords: Ovarian cancer; Cytoreductive surgery; Recurrent ovarian cancer; Retroperitoneal lymphadenectomy; Women cancer global variation
Editor: Basel Refky, MD
Submission deadline: 31 July 2025
Current Update in the Treatment of Cervical Cancer
Keywords: Radical hysterectomy; Fertility Sparing; Oncological Outcomes
Editor: Carlo Ronsini, MD
Submission deadline: 31 December 2024
Gynecological Cancer Prevention: A New Prospective
Keywords: Gynecology; Obstetric and Gynecological Ultrasound; Menopause Obstetrics; Gynecologic Oncology; Gynecologic Pathology
Editor: Ottavia Dʼoria, MD
Submission deadline: 31 October 2023
Molecular Pathological Approach to Uterine Mesenchymal Tumors and Malignant Tumors for the Establishment of New Diagnostic and Therapeutic Methods
Keywords: Leiomyoma; Leiomyosarcoma; Ovarian cancer; Cervical cancer; Endometrial cancer
Editor: Prof. Takuma Hayashi
Submission deadline: 31 October 2023
Molecular Characterization in Endometrial Cancer: Progress and Prospects
Keywords: Endometrial Cancer (EC); Molecular Biomarkers; Immune Checkpoint Inhibitor; Precision Medicine
Editor: Andrea Giannini, MD, PhD
Submission deadline: 31 December 2022
Immunotherapy for Gynecological Oncology
Keywords: Cancer immunotherapy;Cancer vaccination;Immune checkpoint inhibitor;Ovarian cancer;Cervical cancer;Endometrial cancer
Editor: Tadahiro Shoji, MD
Submission deadline: 31 July 2021
Enhanced Recovery of Gynecological Oncology
Keywords: Gynecological Cancer; Enhanced Recovery After Surgery; Minimally Invasive Surgery; Pain Management; Nutritional Support; High Quality Nursing; Psychological Counseling; Complication Management
Editor: Lin Li, MD
Submission deadline: 31 December 2022
Molecular Markers in Ovarian Cancer: Roles in Diagnosis, Prognostic Prediction, and Personalized Therapy
Keywords: Ovarian Cancer;Diagnosis;Prognosis;Treatment Response;Personalized Therapy;Platinum Resistance;Homologous Recombination Deficiency;Immunotherapy;Cytoreduction;Proteomics;Genomics;Prognostic Biomarkers;Diagnostic Biomarkers
Editor: Sharad Ghamande, MD,David Mysona, MD
Submission deadline: 30 March 2022
Featured Article
Real-world bevacizumab utilization and outcomes among women with ovarian cancer in Europe and the United States. DOI: 10.31083/j.ejgo4206181
To Be a Reviewer
If you would like to volunteer to review a manuscript for European Journal of Gynaecological Oncology journal, please click “Review for EJGO” below to register at our submission website or log in our Online Peer Review system. Your name, contact details, and expertise will be automatically added to our database of reviewers.
Review for EJGOJoin Editorial Board
You are welcome to join our editorial board. Our journal produces and issues editorial board certificates for editorial board members, and the journal website will display the names and personal websites of editorial board members to help enhance their scientific influence. Members of the editorial committee are entitled to 1 free publication (both editorial member’s or recommended paper) per year, and other articles over 2 can enjoy 30% discount of publishing fee.
Join Editorial BoardEditor-in-Chief
Prof. Enrique Hernandez, MD, FACOG, FACS.
Dr. Hernandez is the J. Robert Willson Professor and Chair, Obstetrics, Gynecology and Reproductive Sciences of Lewis Katz School of Medicine at Temple University. He is also a professor in Pathology and Laboratory Medicine of Lewis Katz School of Medicine at Temple University. He specializes in comprehensive, compassionate care of women with gynecologic cancer and pre-cancerous conditions, using the most up-to-date and sophisticated diagnostic and treatment tools.